The Notch Pathway in Ovarian Tumors
Author Information
Author(s): Hopfer O, Zwahlen D, Fey M F, Aebi S
Primary Institution: University of Bern, Bern, Switzerland
Hypothesis
The Notch pathway could be involved in the pathogenesis of ovarian carcinomas.
Conclusion
The Notch pathway is expressed in ovarian epithelial tumors, with some elements differentially expressed between adenomas and carcinomas, suggesting it could be a target for ovarian cancer therapies.
Supporting Evidence
- Notch pathway elements were expressed in ovarian epithelial tumors.
- Adenocarcinomas showed higher expression of certain Notch ligands compared to adenomas.
- Transfection with active Notch 1 led to increased cell proliferation in ovarian cancer cells.
Takeaway
This study looked at how a specific pathway in cells, called the Notch pathway, works in ovarian tumors. It found that this pathway is important for understanding how these tumors grow and could help in creating new treatments.
Methodology
The study analyzed 32 ovarian tumor samples and several cell lines using RT-PCR, real-time PCR, and immunoblots to assess the expression of Notch pathway elements.
Limitations
The study did not explore the functional collaboration of Notch with other oncogenes in detail.
Participant Demographics
Patients aged 40–83 years, median age 61, with no prior chemotherapy.
Statistical Information
P-Value
0.04
Statistical Significance
p=0.04
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website